NZ Rheumatology Research Review Issue 36

In this issue:

A validated gout flare definition
Analysing predictors of incident gout risk
DECT clearly reveals tophaceous deposits
Wide variation across countries in bDMARD uptake for SpA
Mortality in the Waikato Hospital SSc cohort
CV safety of febuxostat vs allopurinol in gout
Adverse consequences of chronic oral glucocorticoids in RA
Predicting poor allopurinol response with ABCG2 variants
Factors associated with allopurinol non-responsiveness
Analysing the risk of developing gout by serum urate level

Please login below to download this issue (PDF)